首页> 外文期刊>Urology >Mechanisms of Disease: polymorphisms of androgen regulatory genes in the development of prostate cancer
【24h】

Mechanisms of Disease: polymorphisms of androgen regulatory genes in the development of prostate cancer

机译:疾病机理:前列腺癌发展中雄激素调节基因的多态性

获取原文
获取原文并翻译 | 示例
           

摘要

Androgens are of primary importance in the etiology of prostate cancer, and binding of the androgen dihydrotestosterone to the androgen receptor is thought to stimulate prostate growth. It has been proposed that polymorphisms within key androgen regulatory genes may contribute to an individual's risk of developing prostate cancer. Attributing single polymorphisms to complex, late-onset, chronic diseases such as prostate cancer is probably not feasible, but identification of genes that increase risk will contribute to larger-scale multigenic risk assessment. Here, we review the current status of our knowledge of associations between important androgen regulatory gene polymorphisms and prostate cancer risk.
机译:雄激素在前列腺癌的病因中是最重要的,并且雄激素二氢睾丸激素与雄激素受体的结合被认为刺激前列腺生长。已经提出,关键雄激素调节基因内的多态性可能有助于个体患前列腺癌的风险。将单一多态性归因于复杂的,迟发的慢性疾病(例如前列腺癌)可能是不可行的,但是鉴定增加风险的基因将有助于大规模多基因风险评估。在这里,我们回顾重要的雄激素调节基因多态性与前列腺癌风险之间的关联我们的知识的现状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号